Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

Health Care and Human Services Policy and Oversight

FORTY– NINTH MEETING

2009-2010 Regular Session - February 18, 2010

STATE OF MINNESOTA FORTY- NINTH MEETING
HOUSE OF REPRESENTATIVES EIGHTY-SIXTH SESSION

COMMITTEE ON HEALTH CARE AND HUMAN SERVICES POLICY AND OVERSIGHT
Chairs, Representative Paul Thissen

MINUTES


Representative Tina Liebling, Vice-Chair of the Health Care and Human Services Policy and Oversight Committee, called the meeting to order at 2:50 P.M. on Thursday, February 18, 2010 in Room 200 of the State Office Building.

The Committee Legislative Assistant noted the roll.

Members present:

LIEBLING, Tina (Vice-Chair)
ABELER, Jim
BROD, Laura
BUNN, Julie
FRITZ, Patti
GARDNER, Paul
GOTTWALT, Steve
HAYDEN, Jeff
HUNTLEY, Tom
KELLY, Tim
LAINE, Carolyn
LOEFFLER, Diane
MACK, Tara
MURPHY, Erin
NORTON, Kim
RUUD, Maria
THAO, Cy
TORKELSON, Paul

Members excused:

EMMER, Tom
THISSEN, Paul (Chair)

A quorum was present.

Representative Gardner moved the minutes of February 17, 2010 be adopted. THE MOTION PREVAILED.

HF1847 (Fritz) Health plans required to establish equal out-of-pocket requirements for oral and intravenously administered chemotherapy medications.

Representative Fritz moved that HF1847 be recommended to pass and re-referred to the Committee on Commerce and Labor.

Representative Fritz moved the H1847DE2 amendment. THE AMENDMENT WAS ADOPTED.

Providing testimony in support of the bill:

Thomas Flynn, M.D., President, Minnesota Oncology
David F. Arons, J.D., Director of Government Relations, American Cancer Society, Minnesota
Roxanne and Robert Tisdale, Patient

Providing testimony in opposition to the bill:

Kathryn Kmit, Director of Policy and Government Affairs, Minnesota Council of Health Plans
Cecilia Retelle, Manager, Education and Health Policy, Minnesota Chamber of Commerce

Representative Fritz renewed her motion that HF1847, as amended, be recommended to pass and re-referred to the Committee on Commerce and Labor. THE MOTION PREVAILED.

HF1217 (Gardner) Drug producers required to register and pay a fee, drug collection program funded by drug producers, reports required, account created, penalties provided, categories expanded of persons allowed to possess legend and nonprescription drugs to include those
Health Care and Human Services
Policy and Oversight Committee
February 18, 2010
Page 2



disposing of them, definitions modified, flushing drugs prohibited by health care facilities, and money appropriated.

Representative Gardner moved that HF1217 be recommended to pass and re-referred to the Committee on Public Safety Policy and Oversight.

Representative Gardner moved the H1217A5 amendment. THE AMENDMENT WAS ADOPTED.

Providing testimony in support of the bill:

Sara Noznesky, Manager of Legislative Affairs, Minnesota Medical Association
Catherine Zimmer, Health Care Specialist, Minnesota Technical Assistance Program, University of Minnesota

Providing neutral testimony on the bill:

Sergeant Karl Schreck, Chisago County Sheriff’s Department

Providing testimony in opposition of the bill:

Tom Tevlin, Greenspirit Strategies
Bruce Lott, Mylan

Representative Liebling announced a recess at 4:25 P.M.

Representative Liebling reconvened the meeting at 6:35 P.M. in room 200 of the State Office Building.

Continued testimony:

Marjorie Powell, PhRMA
Phil Griffin, LifeScience Alley
Buzz Anderson, Minnesota Retailer’s Association

Representative Gardner renewed his motion that HF1217, as amended, be recommended to pass and re-referred to the Committee on Public Safety Policy and Oversight. THE MOTION PREVAILED.

The meeting was adjourned at 7:25 P.M.


Rep. Tina Liebling, CHAIR




Urszula Gryska
Committee Legislative Assistant
More Info On This Meeting..
Bills Added:
  • HF1847 (Fritz) - Health plans required to establish equal out-of-pocket requirements for oral and intravenously administered chemotherapy medications.
  • HF1217 (Gardner) - Legend and nonprescription drug possession allowed by those disposing of them, and definitions modified.
Documents:

*Testimony on HF1217 will be limited to the jurisdiction of this committee.